Company Information
USD
4.08
- (-2.6%)
NASDAQ:AUTL, AUTOLUS THERAPEUTICS PLC
Industry: Biotechnology
End of Day: 6 May 2024 GMT-4
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Address
191 Wood Lane
The MediaWorks
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Robert W. Azelby
Director
Dr. Elisabeth Leiderman, M.D.
Director
Dr. Christian Itin, PhD.
CEO/Director
Ms. Cynthia M. Butitta
Director
Mr. John E. Berriman
Director
Mr. John H. Johnson
Chairman of the Board/Director
Mr. William D. Young
Director
Dr. Joseph Anderson, PhD.
Director
Ms. Linda C. Bain
Director
Mr. Christopher Vann
COO/Senior VP
Dr. Martin Murphy, PhD
Director
Mr. David Brochu
Chief Technology Officer/Senior VP
Mr. Brent Rice
Other Executive Officer/Senior VP
Dr. Edgar Braendle
Other Executive Officer/Senior VP
Ms. Lucinda Crabtree
CFO/Senior VP
Ownership
Institution Holdings
Syncona Portfolio Ltd.
21,346,829 (9.188%)
Blackstone Inc
20,485,611 (8.818%)
Paradigm Biocapital Advisors LP
12,611,335 (5.428%)
Deep Track Capital, LP
11,869,297 (5.109%)
Polygon Management Ltd
8,000,000 (3.443%)
Cormorant Asset Management, LLC
5,450,000 (2.346%)
Armistice Capital, LLC
3,850,000 (1.657%)
Adage Capital Partners Gp LLC
3,825,532 (1.647%)
T. Rowe Price Associates, Inc.
3,001,208 (1.292%)
Perpetual Ltd
2,064,731 (0.889%)
Funds Holdings
iShares Biotechnology ETF
819,870 (0.353%)
Regnan Global Equity Impact Solutions Fd
679,199 (0.292%)
Regnan Global Equity Impact Solutions
234,630 (0.101%)
Harbor Disruptive Innovation Fund
215,524 (0.093%)
ERSTE STOCK BIOTEC
195,013 (0.084%)
Pendal Sustainable Balanced Fund
167,298 (0.072%)
iShares Nasdaq US Biotechnology ETF
71,004 (0.031%)
Harbor Disruptive Innovation ETF
67,898 (0.029%)
Pendal Wholesale Plus Active Balanced Fd
33,850 (0.015%)
BT Future Goals BTFM
31,119 (0.013%)
Make Smart Investment Choices